Home
About Karmanos
Media Room
Careers
Contact Us
Print Page
Text Size:
A
A
A
Make an appointment
with a cancer specialist today.
Call us at
800-KARMANOS (800-527-6266)
Patients and Visitors
Make an Appointment
Find a Physician
Cancer Care
Multidisciplinary Teams
Radiology Services
Patient Center
Cancer Lectures & Seminars
Cancer Awareness & Prevention
Locations & Directions
Local Lodging
Visitor Amenities
Visiting Hours & Parking
Healthcare Professionals & Research
Karmanos Research
Cancer Diagnostics Program
Refer a Patient
Find Clinical Trials
Find a Karmanos Physician
Environmental Cancer Program
Phase 1 Clinical Trials Program
Multidisciplinary Teams
Professional Education
Smoking Cessation
Ways to Give
Donations
Action Alerts
Employer Matching Program
Karmanos Events
Planned Giving
Corporate Involvement
Stock Contribution
IRA Charitable Rollover
Goods & Services
Community Partners
Volunteer
Fundraising
Susan G. Komen Detroit Race for the Cure
Related News
Back to Document
Movember is here!
Free Prostate Cancer Symposium Saturday, September 22
What you should know about fibroid tumors
The Facts about Thyroid Cancer
Karmanos, Wayne State research to shed light on bone metastasis in prostate cancer
Prostate Health: Speak with Your Doctor about Appropriate Screening Methods
Compuware Supports Movember Movement for Karmanos, prostate cancer awareness
Karmanos doctors help prostate cancer survivor heal, pursue goal of writing book
Pain pump allows Karmanos patient to realize his dream of opening museum in Lebanon
Herrick Research Challenge invests in future of promising scientists, prostate cancer research
Karmanos Prostate Cancer Researchers Receive Blue Cross Blue Shield of Michigan Foundation Grant
Karmanos' Dr. Harbut studies protein markers that could detect malignant mesothelioma
Karmanos scientists explore role of tumor suppressor gene in inhibiting prostate cancer cell metastasis
Karmanos Cancer Institute researchers conduct world's largest study on use of fast neutron therapy for prostate cancer
The Karmanos Cancer Center one of the first in Michigan to use PROVENGE, the new FDA-approved drug for advanced prostate cancer
Karmanos researchers identify protease that promotes prostate cancer's spread to bone
Karmanos surgeon is Michigan's first to perform transoral robotic surgery on patients
©
2013 Karmanos Cancer Institute
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.
